{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Host",
      "Mortality",
      "Polymorphisms",
      "Prevalence"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35337605",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/bs.acc.2021.07.002",
      "S0065-2423(21)00055-X"
    ],
    "Journal": {
      "ISSN": "2162-9471",
      "JournalIssue": {
        "Volume": "107",
        "PubDate": {
          "Year": "2022"
        }
      },
      "Title": "Advances in clinical chemistry",
      "ISOAbbreviation": "Adv Clin Chem"
    },
    "ArticleTitle": "Host polymorphisms and COVID-19 infection.",
    "Pagination": {
      "StartPage": "41",
      "EndPage": "77",
      "MedlinePgn": "41-77"
    },
    "Abstract": {
      "AbstractText": [
        "Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). There is growing evidence that host genetics play an important role in COVID-19 severity. Based on current knowledge about the human protein machinery for SARS-CoV-2 entry, the host innate immune response, and virus-host interactions, the potential effects of human genetic polymorphisms, which may contribute to clinical differences in SARS-CoV-2 pathogenesis, may help to determine the individual risk for COVID-19 infection and outcome."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Electronic address: joris.delanghe@ugent.be."
          }
        ],
        "LastName": "Delanghe",
        "ForeName": "Joris R",
        "Initials": "JR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Nephrology, Ghent University Hospital, Ghent, Belgium; Research Foundation-Flanders (FWO), Brussels, Belgium."
          }
        ],
        "LastName": "Speeckaert",
        "ForeName": "Marijn M",
        "Initials": "MM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Adv Clin Chem",
    "NlmUniqueID": "2985173R",
    "ISSNLinking": "0065-2423"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymorphism, Genetic"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}